Contact
Please use this form to send email to PR contact of this press release:
ExCellThera receives FDA orphan drug designation for ECT-001 for the prevention of graft-versus-host disease
TO:
Please use this form to send email to PR contact of this press release:
ExCellThera receives FDA orphan drug designation for ECT-001 for the prevention of graft-versus-host disease
TO: